Medicalsystem Biotechnology (300439.SZ) obtained two medical device registration certificates.
Meikang Biotechnology (300439.SZ) announced that the company recently obtained the "Medical Device Registration Certificate (In vitro diagnostic reagent)" issued by the National Medical Products Administration and Zhejiang Provincial Medical Products Administration, including: Hepatitis B virus e antibody detection reagent kit (Chemiluminescent microparticle immunoassay), Golgi protein 73 detection reagent kit (Chemiluminescent microparticle immunoassay).
Medicalsystem Biotechnology (300439.SZ) announced that the company has recently obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagents)" issued by the National Medical Products Administration and the Zhejiang Provincial Medical Products Administration, which includes: Hepatitis B virus e-antibody detection kit (Chemiluminescence Microparticle Immunoassay) and Golgi body protein 73 detection kit (Chemiluminescence Microparticle Immunoassay).
Related Articles

HK Bull/Bear Outstanding Qty Ratio(68:32) | January 10th

Overnight US stocks | S&P 500 index hits new all-time high, Intel Corporation (INTC.US) rises 10.8%

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.
HK Bull/Bear Outstanding Qty Ratio(68:32) | January 10th

Overnight US stocks | S&P 500 index hits new all-time high, Intel Corporation (INTC.US) rises 10.8%

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


